Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1984 1
1985 3
1988 1
1991 1
1992 1
1994 7
1995 3
1996 2
1997 2
1998 5
1999 2
2000 4
2001 10
2002 9
2003 5
2004 3
2005 5
2006 9
2007 9
2008 11
2009 8
2010 9
2011 8
2012 11
2013 14
2014 32
2015 20
2016 15
2017 14
2018 14
2019 21
2020 27
2021 21
2022 13
2023 20
2024 22
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Spiera R, et al. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. Arthritis Rheumatol. 2023. PMID: 37098795 Free article. Clinical Trial.
Nasoenteric tube complications.
Prabhakaran S, Doraiswamy VA, Nagaraja V, Cipolla J, Ofurum U, Evans DC, Lindsey DE, Seamon MJ, Kavuturu S, Gerlach AT, Jaik NP, Eiferman DS, Papadimos TJ, Adolph MD, Cook CH, Stawicki SP. Prabhakaran S, et al. Among authors: nagaraja v. Scand J Surg. 2012;101(3):147-55. doi: 10.1177/145749691210100302. Scand J Surg. 2012. PMID: 22968236 Review.
The Importance of Equity in Health Care.
Nagaraja V, Burgess S. Nagaraja V, et al. J Soc Cardiovasc Angiogr Interv. 2023 Aug 4;2(5):101065. doi: 10.1016/j.jscai.2023.101065. eCollection 2023 Sep-Oct. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39132409 Free PMC article. No abstract available.
Transcatheter Mitral Annuloplasty: Carillon Device.
Nagaraja V, Kapadia SR. Nagaraja V, et al. Interv Cardiol Clin. 2024 Apr;13(2):249-255. doi: 10.1016/j.iccl.2023.12.004. Epub 2024 Jan 20. Interv Cardiol Clin. 2024. PMID: 38432767 Review.
To FFR, or Not to FFR an IRA, That Is the Question.
Nagaraja V, Fearon WF. Nagaraja V, et al. J Soc Cardiovasc Angiogr Interv. 2023 May 2;2(3):100974. doi: 10.1016/j.jscai.2023.100974. eCollection 2023 May-Jun. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39130701 Free PMC article. No abstract available.
Management of scleroderma renal crisis.
Nagaraja V. Nagaraja V. Curr Opin Rheumatol. 2019 May;31(3):223-230. doi: 10.1097/BOR.0000000000000604. Curr Opin Rheumatol. 2019. PMID: 30870219 Review.
343 results